We’re proud that #TriVerity is recognized as a finalist for Emerging Innovator of the Year @CALifeSciences. Public voting is open Oct 1–9. If our work resonates with you, we’d be grateful for your vote. https://t.co/UV6pymqeBO

We’re honored to be named a finalist for Emerging Innovator of the Year at the @CALifeSciences Pantheon Awards. With #TriVerity, we’re redefining how acute infection and sepsis are diagnosed, prognosed, and treated. Voting is open Oct 1–9: https://t.co/UV6pymqeBO

ICU Care Transformed: Precision Medicine Reaches Sepsis and Critical Illness The hope is that the next generation of physicians won’t have to choose between supportive care and prayer. @TimSweeney83 @purveshkhatri @atulbutte @Stanford @Inflammatix_Inc https://t.co/KVOvn3RoFM

“Inflammatix is moving the field of emergency medicine beyond traditional biomarkers and billing codes, bolstering clinical judgment through the embrace of AI-powered immune profiling as a new diagnostic and prognostic standard.” @TimSweeney83 @NatureMedicine

“The three @NatureMedicine publications mark a big paradigm shift in how we think about the diagnosis and care of patients with acute infection and sepsis,” says @Inflammatix_Inc CEO, @TimSweeney83, MD, PhD.

Sepsis is the leading cause of death in US hospitals; yet billions spent on new tests, drugs & policies have done little to improve survival or healthcare costs. Early recognition is critical, but current protocols lack a clear definition of what counts as 'sepsis' v 'not sepsis'

At the center is the SEPSIS-SHIELD study, which validates #TriVerity as a breakthrough AI-powered diagnostic that outperforms the standard of care, transforming hospital triage by providing early clarity on both infection type and illness severity.

We are thrilled to announce three landmark publications in @NatureMedicine that redefine how sepsis is diagnosed and treated. Read today’s release for links to the three papers:

AI-driven host-response testing is transforming the way acute infections are diagnosed and triaged. Join us on Tuesday, Sept. 30 at 4PM ET for a conversation with our CEO @TimSweeney83 on how this innovation is reshaping emergency medicine. Register at https://t.co/xOPVuIKWCj

Just published in the American Journal of Emergency Medicine -- #TriVerity's severity classifier is proven useful in patients with fever & neutropenia to help stratify risk of need for ICU care in this vulnerable population. Read more: https://t.co/3vK3V5Lgvt cc: @BrighamWomens

#ACEP25, let's talk about transforming triage with #TriVerity. Hear from emergency medicine leader Dr. Ed Panacek and Inflammatix CMO Dr. Sam Ajizian on the real-world impact of TriVerity on patient care in the emergency department https://t.co/IIkvDgoJHN #FOAmed #MedTwitter

When the tools get better, the outcomes do too. For those attending #ACEP25, start Monday morning with breakfast & insights from Ed Panacek, MD, MPH, Chair of Emergency Medicine at USA Health, talking about the value TriVerity brings to the ED https://t.co/IIkvDgoJHN #MedTwitter

Fast. Accurate. Reliable. See the newly published, peer-reviewed Analytical Validation study in the Journal of Clinical Microbiology (JCM) validating the #TriVerity Test System as a game-changer for emergency care:

Big news: @CMSGov has granted NTAP reimbursement for #TriVerity, recognizing its unique clinical utility in assessing both infection type and severity in ED patients. Read the full release: https://t.co/7apV9j12lH #Sepsis #Diagnostics #Inflammatix

The leadership behind #TeamInflammatix is expanding in new and exciting ways to meet the demand of the #TriVerity Test System launch! Today, we are thrilled to announce Martín Vazquez as our new Chief Operating Officer🎉 See press release: https://t.co/7OI4jR0xpH

Proud to see our very own Shailee Rasania recognized as a distinguished speaker at the US Medical Device & Diagnostic Post-Market Surveillance Conference this week! #meddevice #qra #clinicaloperations #leadership #medtech

As #LabWeek2025 wraps, we’re celebrating Stephen Gombos, Director of Lab Services at Licking Memorial. From diagnosing acute infections to mentoring future leaders, Stephen's impact is felt across the lab and beyond. Thank you for all you do! #TheLabIsEverything #PatientCare

We had a great time connecting with microbiology leaders at #ESCMIDGlobal! Our Senior Director of Medical Affairs Natalie Whitfield presented the latest data on the science and unique capability behind #TriVerity. Thank you to @ESCMID for hosting such a connective event!

It's #LabWeek2025! So pleased to recognize the incredible laboratorians whose passion for making a difference in the lives of patients is clear from every interaction we have. Please give the lab folks in your life some extra appreciation this week — they deserve it!

Our rockstar Senior Director of Medical Affairs Natalie Whitfield is heading to @ESCMID to represent #TeamInflammatix and educate peers about #TriVerity! Stop by Hall 11 at 11am on April 14th to hear Natalie present new data about our work.